CMC CONSULTING GROUP es un grupo de empresas consultoras de ámbito internacional, focalizada en asuntos regulatorios de productos sanitarios.
Con sede en España, ha establecido distintas oficinas en el Reino Unido, España, Suiza, China, Australia y EEUU. Cuenta con equipos técnicos profesionales de varios campos en todo el mundo, y puede proporcionar servicios personalizados para clientes internacionales basados en las condiciones reales del fabricante.
Noticias y novedades
Australia: New opportunities for medical device and IVD manufacturers
The Therapeutic Goods Administration (TGA) continues to modernize Australia's regulatory system, introducing measures that simplify market access for medical devices and in vitro diagnostics (IVDs). Here’s what’s new and how these updates can impact your business. What’s Changing for Manufacturers? [...]
MHRA updates Post-Market Surveillance: How to adapt your medical devices to new requirements
The Medicines and Healthcare products Regulatory Agency (MHRA) has released official guidance to help medical device manufacturers prepare for the updated Post-Market Surveillance (PMS) requirements, effective June 16, 2025. What is PMS? PMS is a mandatory system designed to [...]
How to Ensure the Safety of Mobility Devices with Lithium Batteries: MHRA Recommendations
Lithium batteries are a critical technology for powering mobility devices such as electric wheelchairs and mobility scooters. However, if not managed properly, they can pose significant risks, including fire hazards that endanger users’ safety. To address these concerns, the MHRA [...]
¿Buscas inversión inmobiliaria?
CMC Group, líderes en consultoría de medical devices, amplía su alcance con Cocolilo House SL, ofreciendo ahora soluciones integrales para inversores en el sector inmobiliario de la Costa del Sol.
